NCT03262831

Brief Summary

The investigators hypothesize that a personalized yoga program with mindful movement implemented during breast cancer therapy will benefit women in multiple ways. The investigators predict that women participating in the program will experience less weight gain and fatigue and will have an improved quality of life compared to women not participating in the program. The investigators predict that this will be associated with decreased markers of inflammation. The investigators will also evaluate whether there is improved pathologic response rate compared to historical controls. This study will provide pilot data for a larger randomized controlled trial assessing whether program can provide long-term improvement in quality of life, weight maintenance, and the serum and tumor changes correlating with a reduced risk of recurrence and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

January 10, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2019

Completed
Last Updated

September 3, 2019

Status Verified

August 1, 2019

Enrollment Period

1.5 years

First QC Date

August 23, 2017

Last Update Submit

August 29, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of enrolling patients to larger randomized controlled trial using yoga and mindful movement as measured the number of eligible patients enrolled

    -Feasibility is defined as the ability to enroll 60% of eligible patients

    Completion of study enrollment (estimated to be 6 months)

  • Feasibility of conducting a larger randomized trial using yoga and mindful movement

    -Feasibility is defined as the ability to have an 80% completion rate of the intervention

    Completion of study enrollment (estimated to be 6 months)

  • Efficacy of yoga exercise as measured by weight change from baseline to completion

    Completion of treatment (estimated to be 6 months)

Secondary Outcomes (4)

  • Effect of yoga exercise as measured by rate of pathologic response (partial and complete) (neoadjuvant subset only)

    Completion of treatment (estimated to be 6 months)

  • Effect of yoga exercise as measured by inflammatory markers

    Completion of treatment (estimated to be 6 months)

  • Effect of yoga exercise as measured by fatigue index

    Completion of treatment (estimated to be 6 months)

  • Effect of yoga exercise as measured by quality of life

    Completion of treatment (estimated to be 6 months)

Study Arms (2)

Arm 1: Yoga

EXPERIMENTAL

* Prior to start of treatment, a yoga therapist will work with each patient to develop a personalized yoga protocol using Gentle Hatha and Restorative Yoga * Each protocol will consist of 5-10 minutes of centering poses to invite focus and relaxation, then 15-20 minutes of seated and standing active poses, ending with 5-10 minutes of guided relaxation. * The personalized practice will be given to each participant and she will be asked to practice beginning at the start of neoadjuvant treatment at least 3 times a week (but preferably daily) at home for at least 30 minutes each time. Participants will continue their personalized yoga practice during the entirety of treatment. Each participant will be asked to journal when and for how long she practices at home and make any comments as to how the practice might have made her feel * During participation, weekly follow-up calls will be made by a member of the study team to each participant randomized to the yoga arm.

Other: YogaProcedure: Blood drawBehavioral: FACT-G questionnaireProcedure: Weight measurementBehavioral: Recent Physical Activity QuestionnaireBehavioral: NHANES Food Questionnaire

Arm 2: No Yoga

ACTIVE COMPARATOR

-Patients in this arm will not receive a personalized yoga plan

Procedure: Blood drawBehavioral: FACT-G questionnaireProcedure: Weight measurementBehavioral: Recent Physical Activity QuestionnaireBehavioral: NHANES Food Questionnaire

Interventions

YogaOTHER

The yoga practice, Gentle Hatha and Restorative Yoga, will be based on protocols that have been found to decease fatigue and weight gain by helping the participant gain insight in recognizing stress responses and ways to relax

Arm 1: Yoga
Blood drawPROCEDURE

* Baseline and end of treatment * To evaluate change in inflammatory markers (CRP, IL-6, and TNF)

Arm 1: YogaArm 2: No Yoga

* 7 statements that other people with breast cancer have said are important, the patient is to circle or mark one number per line to indicate the response as it applies in the last 7 days * Answers range from 0=not at all to 4=very much

Arm 1: YogaArm 2: No Yoga

-Weight will be taken at baseline, on day 1 of each cycle, and the end of treatment

Arm 1: YogaArm 2: No Yoga

-To assess physical activity, the RPAQ will be completed at baseline and at the end of treatment.

Also known as: RPAQ
Arm 1: YogaArm 2: No Yoga

-To assess diet, the NHANES Food Questionnaire will be completed at baseline and at the end of treatment.

Arm 1: YogaArm 2: No Yoga

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Eligibility Critera: * Age ≥ 18. * Female. * Newly diagnosed with Stage I-III breast cancer. * Scheduled to undergo neoadjuvant or adjuvant chemotherapy or neoadjuvant endocrine therapy. * Not currently regularly practicing yoga (defined as at least once a month). * Able to read and understand English * Able to understand and willing to sign an IRB-approved written informed consent document

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Publications (1)

  • Greaney SK, Amin N, Prudner BC, Compernolle M, Sandell LJ, Tebb SC, Weilbaecher KN, Abeln P, Luo J, Tao Y, Hirbe AC, Peterson LL. Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221137285. doi: 10.1177/15347354221137285.

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

YogaBlood Specimen CollectionWeights and Measures

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy ModalitiesSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Lindsay L Peterson, M.D., MSCR

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2017

First Posted

August 25, 2017

Study Start

January 10, 2018

Primary Completion

June 26, 2019

Study Completion

June 26, 2019

Last Updated

September 3, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations